C20orf173

RNA — tumor vs normal
Tumor vs NormalRNABox plot · TCGA cohorts

Across TCGA pan-cancer cohorts, C20orf173 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of C20orf173’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where C20orf173 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types C20orf173 is over-expressed in tumor.

KIRC and BLCA are the cancer types where C20orf173 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in C20orf173 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.
LineageGenderStageFold-changepSampling consensus
KIRCMaleAll+0.015.0063view →
BLCAAllAll+0.026.0212view →
Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

C20orf173–KIRC

Tumor-vs-normal expression box plot for C20orf173 RNA in KIRC.

Open the KIRC breakdown →

Exploration